In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
Despite spending trillions of dollars per year on commercial services, middle market companies are often overlooked by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback